# Finerenone for Patients With Primary Aldosteronism (FAIRY)

Study · id `cardio:ct-nct06457074` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06457074](<https://clinicaltrials.gov/study/NCT06457074>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06457074

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 306 participants.

## Technical summary

Registry record NCT06457074. Randomized; no masking; primary purpose treatment. Start 2024-06-04 (actual); primary completion 2026-04-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 306 participants (enrolled count; ClinicalTrials.gov record NCT06457074, source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)
- Started: 2024-06-04 (actual) (ClinicalTrials.gov record NCT06457074, source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)
- Primary completion: 2026-04-20 (actual) (ClinicalTrials.gov record NCT06457074, source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)
- Completion: 2026-04-20 (actual) (ClinicalTrials.gov record NCT06457074, source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06457074, source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06457074-2026-09-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: Finerenone for Patients With Primary Aldosteronism (FAIRY)
- Condition: Primary Aldosteronism
- Intervention (Drug): Finerenone Oral Tablet
- Intervention (Drug): Spironolactone Oral Tablet
- Lead sponsor: Chongqing Medical University
- Lead sponsor class: OTHER
- Collaborator: Affiliated Hospital of Southwest Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital, Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: Chuxiong Yi Autonomous Prefecture People's Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Kunming Medical University
- Collaborator class: OTHER
- Collaborator: Shanghai Public Health Clinical Center
- Collaborator class: OTHER\_GOV
- Collaborator: Tianjin Medical University General Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital with Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: Second Xiangya Hospital of Central South University
- Collaborator class: OTHER
- Collaborator: WanSheng People's Hospital of ChongQing
- Collaborator class: UNKNOWN
- Collaborator: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator class: OTHER
- Collaborator: Affiliated Hospital of Nantong University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Primary aldosteronism (`cardio:primary-aldosteronism`)
- Registry lists this organization as the lead sponsor: Chongqing Medical University (`cardio:org-chongqing-medical-university`)
- Registry lists this organization as a collaborator: First Affiliated Hospital, Sun Yat-Sen University (`cardio:org-first-affiliated-hospital-sun-yat-sen-university`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Kunming Medical University (`cardio:org-first-affiliated-hospital-of-kunming-medical-university`)
- Registry lists this organization as a collaborator: Tianjin Medical University General Hospital (`cardio:org-tianjin-medical-university-general-hospital`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)
- Registry lists this organization as a collaborator: Second Xiangya Hospital of Central South University (`cardio:org-second-xiangya-hospital-of-central-south-university`)
- Registry lists this organization as a collaborator: Affiliated Hospital of Nantong University (`cardio:org-affiliated-hospital-of-nantong-university`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Chongqing Medical University (`cardio:org-first-affiliated-hospital-of-chongqing-medical-university`)

## Provenance

Content hash: 9f3a6b7f793eb52c4cc438c58dec4a64fbf0ce001d190f84114cefd2578093bf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
